SCHEMBL679457

SCHEMBL679457

CCCCCCN(C=C(CC)C(=O)O)CCN(CCN(C=C(CC)C(=O)O)CCCCCC)CCN(C=C(CC)C(=O)O)CCCCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 3/20 0.38
PHF8 Q9UPP1 2/20 0.38
KDM4C Q9H3R0 1/20 0.38
EP300 Q09472 1/20 0.36
ICMT O60725 1/20 0.35
ALB P02768 1/20 0.35
EPHX2 P34913 3/20 0.34
GPR84 Q9NQS5 7/20 0.33
PPARG P37231 6/20 0.33
PPARD Q03181 6/20 0.33
PPARA Q07869 6/20 0.33
HDAC11 Q96DB2 5/20 0.33
TSHR P16473 4/20 0.33
ALDH1A1 P00352 2/20 0.33
TLR2 O60603 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
FABP4 P15090 2/20 0.33
PTPN1 P18031 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
SLC22A8 Q8TCC7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6449857 0.93 EP300 (0.40) EP300EPHX2GPR84PPARGPPARD
SCHEMBL7630004 0.86 CA12 (0.36) KDM5AKDM4CEP300EPHX2GPR84
SCHEMBL10347252 0.80 DNM1 (0.33) EP300EPHX2ALDH1A1TDP1MEN1
SCHEMBL10694350 0.79 GPR84 (0.36) EP300GPR84PPARDZDHHC20FFAR1
SCHEMBL6446570 0.79 CA12 (0.32) TSHR
SCHEMBL3277773 0.75 EP300 (0.44) KDM5APHF8KDM4CEP300ICMT
SCHEMBL3282826 0.75 EP300 (0.44) KDM5APHF8KDM4CEP300ICMT
SCHEMBL3284713 0.75 EP300 (0.44) KDM5APHF8KDM4CEP300ICMT
SCHEMBL3285692 0.74 EP300 (0.41) EP300EPHX2GPR84PPARGPPARD
SCHEMBL8755479 0.74 AKR1B1 (0.35) KDM5AKDM4CEPHX2GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110286935-A1 Multi-Functional Nano-Device ATRP Solutions, Inc. (US) 2011-11-24 US disclosed
US-7019082-B2 Polymers, supersoft elastomers and methods for preparing the same CARNEGIE MELLON UNIVERSITY (US) 2006-03-28 US disclosed
EP-1534764-A2 POLYMERS, SUPERSOFT ELASTOMERS AND METHODS FOR PREPARING THE SAME CARNEGIE-MELLON UNIVERSITY (US) 2005-06-01 EP disclosed
US-20040110893-A1 Polymers, supersoft elastomers and methods for preparing the same CARNEGIE MELLON UNIVERSITY 2004-06-10 US disclosed
WO-2004014963-A2 POLYMERS, SUPERSOFT ELASTOMERS AND METHODS FOR PREPARING THE SAME CARNEGIE MELLON UNIVERSITY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110286935-A1 Multi-Functional Nano-Device CD47, FCGRT, FCGR3B KDM5A 3742/4885PHF8 3607/4885KDM4C 3662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.